Beta Bionics (NASDAQ:BBNX) Price Target Raised to $20.00 at Bank of America

Beta Bionics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

IRVINE, Calif., Sept. 15, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX) today announced the pricing of an underwritten public offering of 7,652,175 shares of its common stock at a price to the public of $17.25 per share and,…

Beta Bionics plans $125M public offering; shares down (NASDAQ:BBNX)

Beta Bionics (BBNX) plans a $125M stock offering to fund Mint commercialization, manufacturing, R&D and more.

Beta Bionics (NASDAQ:BBNX) Price Target Raised to $20.00 at Bank of America

Bank of America upped their price objective on Beta Bionics from $18.00 to $20.00 and gave the stock a "neutral" rating in a research report on Tuesday.

Beta Bionics (NASDAQ: BBNX) Faces Securities Class Action Amid iLet FDA Compliance

Beta Bionics, Inc. (BBNX) Securities Class Action Hagens Berman Highlights Lawsuit Targeting Beta Bionics, Inc. (BBNX) Over Alleged Misleading Statements SAN FRANCISCO, Sept. 16, 2026 (GLOBE NEWSWIRE) — Beta Bionics, Inc. (NASDAQ: BBNX) faces a securities class action, which seeks to represent investors who purchased or otherwise acquired shares of the company’s common stock between [...]